Nina Treder

Ms. Nina Treder

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
CMConstanza Morén
Constanza Morén
NTNina Treder
Nina Treder
AMAlbert Martínez-Pinteño
Albert Martínez-Pinteño
NRNatàlia Rodríguez
Natàlia Rodríguez
NANéstor Arbelo
Néstor Arbelo
EPEduard Parellada
Eduard Parellada
Schizophrenia (SZ) is a deleterious brain disorder affecting cognition, emotion and reality perception. The most widely accepted neurochemical-hypothesis is the imbalance of neurotransmitter-systems. Depleted GABAergic-inhibitory function might produce a regionally-located dopaminergic and glutamatergic-storm in the brain. The dopaminergic-release may underlie the positive psychotic-symptoms while the glutamatergic-release could prompt the primary negative symptoms/cognitive deficits. This may occur due to excessive synaptic-pruning during the neurodevelopmental stages of adolescence/early adulthood. Thus, although SZ is not a neurodegenerative disease, it has been suggested that exaggerated dendritic-apoptosis could explain the limited neuroprogression around its onset. This apoptotic nature of SZ highlights the potential therapeutic action of anti-apoptotic drugs, especially at prodromal stages. If dysregulation of apoptotic mechanisms underlies the molecular basis of SZ, then anti-apoptotic molecules could be a prodromal therapeutic option to halt or prevent SZ. In fact, risk alleles related in apoptotic genes have been recently associated to SZ and shared molecular apoptotic changes are common in the main neurodegenerative disorders and SZ. PRISMA-guidelines were considered. Anti-apoptotic drugs are commonly applied in classic neurodegenerative disorders with promising results. Despite both the apoptotic-hallmarks of SZ and the widespread use of anti-apoptotic targets in neurodegeneration, there is a strikingly scarce number of studies investigating anti-apoptotic approaches in SZ. We analyzed the anti-apoptotic approaches conducted in neurodegeneration and the potential applications of such anti-apoptotic therapies as a promising novel therapeutic strategy, especially during early stages.

Verified
Journal Article
Open access
PDF file
NTNina Treder
Nina Treder
AMAlbert Martínez-Pinteño
Albert Martínez-Pinteño
NFNatalia Rodriguez Ferret
Natalia Rodriguez Ferret
NANéstor Arbelo
Néstor Arbelo
SMSantiago Madero
Santiago Madero
CMConstanza Morén
Constanza Morén
Schizophrenia (SZ) is a heterogeneous mental disorder, affecting ~1% of the worldwide population. One of the main pathophysiological theories of SZ is the imbalance of excitatory glutamatergic pyramidal neurons and inhibitory GABAergic interneurons, involving N-methyl-D-aspartate receptors (NMDAr). This may lead to local glutamate storms coupled with excessive dendritic pruning and subsequent cellular stress, including nitrosative stress, during a critical period of neurodevelopment, such as adolescence. Nitrosative stress is mediated by nitric oxide (NO), which is released by NO synthases (NOS) and has emerged as a key signaling molecule implicated in SZ. Regarding glutamatergic models of SZ, the administration of NMDAr antagonists has been found to increase NOS levels in the prefrontal cortex (PFC) and ventral hippocampus (HPC). We hypothesized that suboptimal NOS function in adolescence could be a target for early treatments, including clozapine (CLZ) and the novel metabotropic glutamate receptor modulator JNJ-46356479 (JNJ). We analyzed the protein levels of NOS isoforms in adult PFC and HPC of a postnatal ketamine induced murine model of SZ receiving CLZ or JNJ during adolescence by western blot. Endothelial NOS and neuronal NOS increased under ketamine administration in PFC and decreased in CLZ or JNJ treatments. The same trends were found in the HPC in neuronal NOS. In contrast, inducible NOS was increased under JNJ treatment with respect to ketamine induction in the HPC, and the same trends were found in the PFC. Taken together, our findings suggest a misbalance of the NOS system following NMDAr antagonist administration, which was then modulated under early CLZ and JNJ treatments.

23 October 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
NTNina Treder
Nina Treder
SFSunniva Fenn-Moltu
Sunniva Fenn-Moltu
SOStuart Oldham
Stuart Oldham
QCQianwen Chang
Qianwen Chang
JOJonathan O’MUircheartaigh
Jonathan O’MUircheartaigh
DBDafnis Batalle
Dafnis Batalle
The cerebellum makes a critical contribution to cognitive and behavioural function, extending well beyond motor control, and is recognised as an important determinant of neurodevelopmental outcome. Despite this, little is known about the foundations of cerebellar functional organisation in early life. Addressing this gap is essential for establishing typical developmental trajectories against which atypical development can be assessed. Here, we analysed fMRI data from term-born neonates (n=155) scanned between 37 and 44 weeks postmenstrual age and mapped intra-cerebellar and cerebro-cerebellar functional connectivity across multiple levels of organisation. We identified 13 intrinsic connectivity networks (ICNs) within the neonatal cerebellum that recapitulated adult subdivisions, with two ICNs showing age-related increases in coverage and strength. Analysis of cerebro-cerebellar connectivity identified 15 sensory, motor and association cerebral clusters, seven increasing connectivity with age. Functional gradient analysis identified a continuous axis from somatomotor to association regions within intra-cerebellar and cerebro-cerebellar organisation, which became more pronounced with age. Together, these findings suggest that the foundations of adult cerebellar functional organisation are present at birth but undergo rapid and regionally heterogeneous maturation over the first weeks of postnatal life. This developmental framework provides a normative reference for understanding cerebellar development and its implications for later neurodevelopmental variation.